<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">fatal </span>
   <span class="font23">response </span>
   <span class="font22">patients </span>
   <span class="font21">IgG </span>
   <span class="font20">immune </span>
   <span class="font20">levels </span>
   <span class="font20">samples </span>
   <span class="font20">EBOV </span>
   <span class="font20">Ebola </span>
   <span class="font19">IgM </span>
   <span class="font18">expression </span>
   <span class="font18">late </span>
   <span class="font18">{border-style </span>
   <span class="font17">EVD </span>
   <span class="font17">infection </span>
   <span class="font17">px;} </span>
   <span class="font17">virus </span>
   <span class="font16">#ffffff;} </span>
   <span class="font16">DSO </span>
   <span class="font16">survivor </span>
   <span class="font16">anti-EBOV </span>
   <span class="font16">cytokines </span>
   <span class="font16">inflammatory </span>
   <span class="font16">gene </span>
   <span class="font16">group </span>
   <span class="font16">performed </span>
   <span class="font16">phase </span>
   <span class="font16">study </span>
   <span class="font16">survivors </span>
   <span class="font15">observed </span>
   <span class="font15">Sierra </span>
   <span class="font14">acute </span>
   <span class="font14">plasma </span>
   <span class="font14">control </span>
   <span class="font14">number </span>
   <span class="font14">significant </span>
   <span class="font14">[]. </span>
   <span class="font14">chemokines </span>
   <span class="font14">compared </span>
   <span class="font14">correlation </span>
   <span class="font14">mRNA </span>
   <span class="font14">viral </span>
   <span class="font14">viremia </span>
   <span class="font13">&amp;lt; </span>
   <span class="font13">(Figure </span>
   <span class="font13">CCL, </span>
   <span class="font13">Table </span>
   <span class="font13">Virus </span>
   <span class="font13">antibody </span>
   <span class="font13">cases </span>
   <span class="font13">differences </span>
   <span class="font13">humoral </span>
   <span class="font13">patients, </span>
   <span class="font13">using </span>
   <span class="font13">versus </span>
   <span class="font13">CCL </span>
   <span class="font13">CXCL, </span>
   <span class="font13">Log </span>
   <span class="font13">S). </span>
   <span class="font13">analyzed </span>
   <span class="font13">collected </span>
   <span class="font13">disease </span>
   <span class="font13">human </span>
   <span class="font13">infection. </span>
   <span class="font13">outcome </span>
   <span class="font13">positive </span>
   <span class="font13">px; </span>
   <span class="font13">specific </span>
   <span class="font13">{font-family </span>
   <span class="font12">RNA </span>
   <span class="font12">antibodies </span>
   <span class="font12">cells </span>
   <span class="font12">cytokine </span>
   <span class="font12">detected </span>
   <span class="font12">early </span>
   <span class="font12">font-size </span>
   <span class="font12">mean </span>
   <span class="font12">outbreak </span>
   <span class="font12">role </span>
   <span class="font12">showed </span>
   <span class="font12">tested </span>
   <span class="font12">Analysis </span>
   <span class="font12">EBOV-RNA/mL: </span>
   <span class="font12">Figure </span>
   <span class="font12">Leone </span>
   <span class="font12">Response </span>
   <span class="font12">[,]. </span>
   <span class="font12">addition, </span>
   <span class="font12">analysis </span>
   <span class="font12">considered </span>
   <span class="font12">double; </span>
   <span class="font12">fold </span>
   <span class="font12">involved </span>
   <span class="font12">load </span>
   <span class="font12">results </span>
   <span class="font12">slides </span>
   <span class="font12">used </span>
   <span class="font12">Emergency </span>
   <span class="font12">Goderich </span>
   <span class="font12">Infect. </span>
   <span class="font12">Leone) </span>
   <span class="font12">PCR </span>
   <span class="font12">[grant </span>
   <span class="font12">adaptive </span>
   <span class="font12">bold </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">change </span>
   <span class="font12">correlated </span>
   <span class="font12">data </span>
   <span class="font12">dysregulation </span>
   <span class="font12">ebola </span>
   <span class="font12">field </span>
   <span class="font12">following </span>
   <span class="font12">genes </span>
   <span class="font12">kinetics </span>
   <span class="font12">longitudinal </span>
   <span class="font12">mediators </span>
   <span class="font12">mediators, </span>
   <span class="font12">negative </span>
   <span class="font12">phases </span>
   <span class="font12">present </span>
   <span class="font12">profile </span>
   <span class="font12">progression </span>
   <span class="font12">reported </span>
   <span class="font12">solid; </span>
   <span class="font12">studies </span>
   <span class="font12">survived </span>
   <span class="font12">time </span>
   <span class="font12">titre </span>
   <span class="font12">titres </span>
   <span class="font12">values </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">(.%) </span>
   <span class="font11">(Freetown, </span>
   <span class="font11">(Table </span>
   <span class="font11">Array </span>
   <span class="font11">CXCL </span>
   <span class="font11">EVD-positive </span>
   <span class="font11">IgM, </span>
   <span class="font11">Immune </span>
   <span class="font11">Italian </span>
   <span class="font11">[,,]. </span>
   <span class="font11">amplification </span>
   <span class="font11">associated </span>
   <span class="font11">cohort </span>
   <span class="font11">collection </span>
   <span class="font11">contribute </span>
   <span class="font11">courier; </span>
   <span class="font11">days </span>
   <span class="font11">described </span>
   <span class="font11">em; </span>
   <span class="font11">excessive </span>
   <span class="font11">failure </span>
   <span class="font11">group, </span>
   <span class="font11">healthy </span>
   <span class="font11">high </span>
   <span class="font11">humans </span>
   <span class="font11">important </span>
   <span class="font11">included </span>
   <span class="font11">including </span>
   <span class="font11">infection, </span>
   <span class="font11">innate </span>
   <span class="font11">key </span>
   <span class="font11">mainly </span>
   <span class="font11">mechanisms </span>
   <span class="font11">onset </span>
   <span class="font11">pro-inflammatory </span>
   <span class="font11">pt;} </span>
   <span class="font11">relation </span>
   <span class="font11">sample </span>
   <span class="font11">secreted </span>
   <span class="font11">shown </span>
   <span class="font11">statistical </span>
   <span class="font11">study, </span>
   <span class="font11">suggesting </span>
   <span class="font11">survivors, </span>
   <span class="font11">timeframe </span>
   <span class="font11">upregulation </span>
  </p>
 </body>
</html>
